Mohamed Shelan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 19

Top Topics

Radical Prostatectomy

Radiation Induced

Top Venues

Prostate cancer and prostatic diseases

NPJ digital medicine

This page only lists publications with an associated author ORCID identifier.

Publications

María Antonia Gómez-Aparicio, Fernando López-Campos, David Buchser, Antonio Lazo, Patricia Willisch, Abrahams Ocanto, Paul Sargos, Mohamed Shelan, Felipe Couñago
Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer? Cancers 16 (13) (2024)
Ali Janbain, Andrea Farolfi, Armelle Arnoux, Louis Romengas, Sophia Scharl, Stefano Fanti, Francesca Serani, Jan C Peeken, Sandrine Katsahian, Iosif Strouthos, Konstantinos Ferentinos, Stefan A Koerber, Marco M E Vogel, Stephanie Elisabeth Combs, Alexis Vrachimis, Alessio Giuseppe Morganti, Simon K B Spohn, Anca-Ligia Grosu, Francesco Ceci, Christoph Henkenberens, Stephanie G C Kroeze, Matthias Guckenberger, Claus Belka, Peter Bartenstein, George Hruby, Louise Emmett, Ali Afshar Omerieh, Nina-Sophie Schmidt-Hegemann, Lucas Mose, Daniel Matthias Aebersold, Constantinos Zamboglou, Thomas Wiegel, Mohamed Shelan
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study. JMIR cancer 10 (2024)
Etienne Mathier, Alexander Althaus, Daniel Zwahlen, Jens Lustenberger, Constantinos Zamboglou, Berardino De Bari, Daniel M Aebersold, Matthias Guckenberger, Thomas Zilli, Mohamed Shelan
HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol. BMJ open 14 (1) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Aurélie Pahud de Mortanges, Haozhe Luo, Shelley Zixin Shu, Amith Kamath, Yannick Suter, Mohamed Shelan, Alexander Pöllinger, Mauricio Reyes
Orchestrating explainable artificial intelligence for multimodal and longitudinal data in medical imaging. NPJ digital medicine 7 (1) (2024)
Etienne Mathier, Alexander Althaus, Daniel Zwahlen, Jens Lustenberger, Constantinos Zamboglou, Berardino De Bari, Daniel M Aebersold, Matthias Guckenberger, Thomas Zilli, Mohamed Shelan
HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol. BMJ open 14 (1) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Aurélie Pahud de Mortanges, Haozhe Luo, Shelley Zixin Shu, Amith Kamath, Yannick Suter, Mohamed Shelan, Alexander Pöllinger, Mauricio Reyes
Orchestrating explainable artificial intelligence for multimodal and longitudinal data in medical imaging. NPJ digital medicine 7 (1) (2024)
Osama Mohamad, Yun Rose Li, Felix Y Feng, Julian C Hong, Anthony Wong, Zakaria El Kouzi, Mohamed Shelan, Thomas Zilli, Peter Carroll, Mack Roach
Delayed definitive management of localized prostate cancer: what do we know? Prostate cancer and prostatic diseases (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases (2024)
Aurélie Pahud de Mortanges, Haozhe Luo, Shelley Zixin Shu, Amith Kamath, Yannick Suter, Mohamed Shelan, Alexander Pöllinger, Mauricio Reyes
Orchestrating explainable artificial intelligence for multimodal and longitudinal data in medical imaging. NPJ digital medicine 7 (1) (2024)
Etienne Mathier, Alexander Althaus, Daniel Zwahlen, Jens Lustenberger, Constantinos Zamboglou, Berardino De Bari, Daniel M Aebersold, Matthias Guckenberger, Thomas Zilli, Mohamed Shelan
HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol. BMJ open 14 (1) (2024)
Osama Mohamad, Yun Rose Li, Felix Y Feng, Julian C Hong, Anthony Wong, Zakaria El Kouzi, Mohamed Shelan, Thomas Zilli, Peter Carroll, Mack Roach
Delayed definitive management of localized prostate cancer: what do we know? Prostate cancer and prostatic diseases (2024)
María Antonia Gómez-Aparicio, Fernando López-Campos, David Buchser, Antonio Lazo, Patricia Willisch, Abrahams Ocanto, Paul Sargos, Mohamed Shelan, Felipe Couñago
Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer? Cancers 16 (13) (2024)
Mohamed Shelan, Vérane Achard, Felix Appiagyei, Lucas Mose, Thomas Zilli, Christian D Fankhauser, Constantinos Zamboglou, Osama Mohamad, Daniel Matthias Aebersold, Richard Cathomas
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases 27 (3) (2024)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)
Sonja Adebahr, Alexander Althaus, Sophia Scharl, Iosif Strouthos, Andrea Farolfi, Francesca Serani, Helena Lanzafame, Christian Trapp, Stefan A Koerber, Jan C Peeken, Marco M E Vogel, Alexis Vrachimis, Simon K B Spohn, Anca-Ligia Grosu, Stephanie G C Kroeze, Matthias Guckenberger, Stefano Fanti, George Hruby, Louise Emmett, Claus Belka, Nina-Sophie Schmidt-Hegemann, Christoph Henkenberens, Daniel M Aebersold, Thomas Wiegel, Ali Afshar-Oromieh, Constantinos Zamboglou, Mohamed Shelan
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy. European journal of nuclear medicine and molecular imaging (2023)
Christina Schröder, Lucas Mose, Etienne Mathier, Daniel Rudolf Zwahlen, Daniel Matthias Aebersold, Robert Foerster, Mohamed Shelan
Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis. Cancers 15 (24) (2023)